Skip to content

Clinical trials

Hepatitis B, Chronic trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B, Chronic Country / region: Hong Kong Clear all

87 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20053
20062
20073
20082
20093
20112
20122
20133
20142
20153
20167
20175
20187
20193
202011
20216
20226
20235
20245
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed53
Terminated15
Active, not recruiting6
Recruiting6
Withdrawn3
Unknown status2
Enrolling by invitation1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche13
Gilead Sciences9
GlaxoSmithKline9
The University of Hong Kong8
Assembly Biosciences7
Chinese University of Hong Kong6
Vir Biotechnology, Inc.5
Aligos Therapeutics3
Arbutus Biopharma Corporation3
AusperBio Therapeutics Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B, Chronic87
Hepatitis B27
Hepatitis9
Hepatitis, Chronic3
Bronchiolitis Obliterans Syndrome2
Fibrosis2
Liver Diseases2
Chronic Disease1
Colitis, Ulcerative1
Crohn Disease1

Trials

Showing 26 to 50 of 87. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.